Glenda M Davison
Overview
Explore the profile of Glenda M Davison including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weale C, Schroeder C, Matshazi D, Davids S, Erasmus R, Kengne A, et al.
J Diabetes Investig
. 2024 Aug;
15(10):1377-1389.
PMID: 39087408
Aims: This study aims to investigate miR-486-5p and miR-novel-chr1_40444 expressions in dysglycemic individuals. Validating RNA-sequencing findings in a larger sample via reverse transcription qPCR (RT-qPCR), we aim to address global...
2.
Prince Y, Davison G, Davids S, Erasmus R, Kengne A, Raghubeer S, et al.
Heliyon
. 2024 Jun;
10(10):e31559.
PMID: 38831830
Disturbances in the oral microbiota may be due to several mechanisms and factors, such as smoking. An imbalance in oral bacteria may result in changes to the innate immune system...
3.
Davison G, Opie J, Davids S, Mohammed R, Novitzky N
Transpl Immunol
. 2024 Apr;
84:102045.
PMID: 38641148
Background: Allogeneic stem cell transplantation (SCT) is a critical therapy for haematological malignancy but may lead to acute and chronic graft versus host disease (GvHD). T-cell depletion with alemtuzumab, either...
4.
van Rensburg J, Davids S, Smuts C, Davison G
Afr J Lab Med
. 2023 May;
12(1):2104.
PMID: 37151816
Background: Sepsis is characterised by multi-organ failure due to an uncontrolled immune response to infection. Sepsis prevalence is increased in developing countries and requires prompt diagnosis and treatment. Reports, although...
5.
Prince Y, Davison G, Davids S, Erasmus R, Kengne A, Graham L, et al.
Biomedicines
. 2023 Jan;
11(1).
PMID: 36672511
The oral microbiota plays a crucial role in both systemic inflammation and metabolic syndrome (MetS), which is characterised by low-grade inflammation. Studies have analysed the gut microbiota using stool specimens...
6.
Matshazi D, Weale C, Erasmus R, Kengne A, Davids S, Raghubeer S, et al.
Front Genet
. 2021 Oct;
12:710438.
PMID: 34594360
MicroRNAs are non-coding, post-transcriptional regulators of gene expression and their dysregulation has been associated with development of various diseases, including hypertension. Consequently, understanding their role in the pathogenesis and progression...
7.
Weale C, Matshazi D, Davids S, Raghubeer S, Erasmus R, Kengne A, et al.
Front Genet
. 2021 Sep;
12:702410.
PMID: 34567065
The influence of disease duration and anti-diabetic treatment on epigenetic processes has been described, with limited focus on interactions with microRNAs (miRNAs). miRNAs have been found to play key roles...
8.
Weale C, Matshazi D, Davids S, Raghubeer S, Erasmus R, Kengne A, et al.
Diagnostics (Basel)
. 2021 Jun;
11(6).
PMID: 34073154
This cross-sectional study investigated the association of miR-1299, -126-3p and -30e-3p with and their diagnostic capability for dysglycaemia in 1273 (men, = 345) South Africans, aged >20 years. Glycaemic status...
9.
Matshazi D, Weale C, Erasmus R, Kengne A, Davids S, Raghubeer S, et al.
Front Cardiovasc Med
. 2021 May;
8:645541.
PMID: 33937359
Hypertension has a complex pathogenesis and symptoms appear in advanced disease. Dysregulation of gene expression regulatory factors like microRNAs has been reported in disease development. Identifying biomarkers which could help...
10.
Matshazi D, Weale C, Erasmus R, Kengne A, Davids S, Raghubeer S, et al.
Mol Biol Rep
. 2021 Mar;
48(3):2553-2560.
PMID: 33759050
MicroRNAs are important in development of disease, and description of novel microRNAs adds to the pool of microRNAs that can be targeted for diagnostic and therapeutic purposes in disease. Herein,...